![]() |
||||||||||||
Introduction
Case report
![]() At the time of her admission to hospital, physical examination and routine blood examinations were normal, except for total cholesterol 260 mg/dL, high-density lipoprotein cholesterol 59 mg/dL, low-density lipoprotein cholesterol 177 mg/dL, and triglycerides 120 mg/dL. Echocardiography showed a normal contractile function and a normal left ventricular ejection fraction (60%). Coronary angiography showed a single-vessel disease of the left anterior descending coronary artery (LAD), with proximal stenosis and a long distal stenosis (Figure 2). Fractional flow reserve at the level of the proximal stenosis was 0.88 at baseline and 0.70 after intracoronary adenosine. Successful percutaneous transluminal coronary angioplasty (PTCA) and stenting (drug eluting stents: Cypher 3.0 × 18 mm plus 3.0 × 8 mm) of the proximal lesion were performed (Figure 3).
![]()
![]() Treatment on discharge included candesartan and hydrochlorothiazide, ticlopidine, and simvastatin (the patient was allergic to ramipril and aspirin). One month later, the exercise stress test was repeated, but it was stopped at the beginning of the 2nd step of the modified Bruce protocol because of chest pain and downward sloping ST-segment depression (> 2 mm) in leads V4–V6. Maximal heart rate was 172 beats/min and maximal blood pressure was 150/90 mm Hg (RPP 25 800) (Figure 4). Calcium-channel blockers (60 mg three times a day) and nitrates (20 mg three times a day) were added to the medication because of persistent chest pain on effort.
![]() In May 2005, the patient was re-admitted to our Cardiology Department. Coronary angiography showed a patent proximal LAD. Fractional flow reserve at the level of the distal LAD stenosis was measured and was 0.83 at baseline and 0.71 after intracoronary adenosine. PTCA followed by implantation of a drug eluting stent was performed at this level (Figure 5).
![]() One month after the second procedure, an exercise stress test was again stopped, at the beginning of the 3rd step of the modified Bruce protocol, because of chest pain and downward sloping ST-segment depression in precordial leads V4–V6 (Figure 6). Maximal heart rate was 161 beats/min and maximal blood pressure was 220/110 mm Hg (RPP 35 420). Drug therapy was modified by the addition of isosorbide mononitrate, verapamil, and bisoprolol.
![]() Six months later the patient was still complaining of persistent angina and a stress test was again stopped, at the 2nd step of the modified Bruce protocol, because of chest pain and horizontal ST-segment depression in precordial leads V4–V6 (Figure 7). Maximal heart rate was 137 beats/min and maximal blood pressure was 220/120 mm Hg (RPP 30 140).
![]() A single photon emission computed tomography perfusion study was consistent with a diffuse defect in subendocardial perfusion.
Discussion REFERENCES 1. Henderson RA, Pocock SJ, Clayton TC, et al., for the Second Randomized Intervention Treatment of Angina (RITA-2) Trial Participants.Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42:1161–1170. PMID: 14522473 [PubMed - indexed for MEDLINE] 2. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321:73–77. PMID: 10884254 [PubMed - indexed for MEDLINE] 3. Hueb W, Soares PR, Gersh BJ, et al. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743–1751. PMID: 15145093 [PubMed - indexed for MEDLINE] 4. Serruys PW, Unger F, Sousa JE, et al., for the Arterial Revascularization Therapies Study Group (ARTS). Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124. PMID: 11297702 [PubMed - indexed for MEDLINE] 5. Serruys PW, Ong AT, van Herwerden LA, et al. Five years outcomes after coronary stenting versus by-pass surgery for the treatment of multivessel disease. The final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575–581. PMID: 16098418 [PubMed - indexed for MEDLINE] 6. Lemos PA, Hoye A, Serruys PW. Recurrent angina after revascularization: an emerging problem for the clinician. Coron Artery Dis. 2004;15(suppl 1):S11–S15. 7. Marzilli M, Sambuceti G, Testa R, Fedele S. Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina. J Am Coll Cardiol. 2002;40:2102–2109. PMID: 12505220 [PubMed - indexed for MEDLINE] 8. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and severity of coronary-artery stenosis. N Engl J Med. 1994;330:1782–1788. PMID: 8190154 [PubMed - indexed for MEDLINE] 9. Sambuceti G, Marzilli M, Marraccini M, et al. Coronary vasocostriction during myocardial ischemia induced by rises in metabolic demand in patients with coronary artery disease. Circulation. 1997;95:2652–2659. PMID: 9193434 [PubMed - indexed for MEDLINE] 10. Marzilli M. Angina “persistente”: l’approccio metabolico può essere una risposta adeguata? Ital Heart J. 2004;5(suppl 2):37S–41S. |
||||||||||||
|
Although great care has been taken in compiling
the information given in this website,
the publisher or the sponsor is not responsible for the continued currency of the information, for any errors or omissions, or for any consequence arising therefrom. © 2009 Les Laboratoires Servier Updates |
||||||||||||